Curcumin for depression: a meta-analysis

References

• Ahern, E., and M. Semkovska. 2017. Cognitive functioning in the first-episode of major depressive disorder: A systematic review and meta-analysis. Neuropsychology 31 (1):52. doi: 10.1037/neu0000319.
   PubMed Web of Science ®Google Scholar
• Al-Karawi, D., Al Mamoori, D. A., and Y. Tayyar. 2016. The role of curcumin administration in patients with major depressive disorder: Mini meta‐analysis of clinical trials. Phytotherapy Research 30:175–83. doi: 10.1002/ptr.5524.
   PubMed Web of Science ®Google Scholar
• Almeida, O. P., G. J. Hankey, B. B. Yeap, J. Golledge, and L. Flicker. 2017. Depression as a modifiable factor to decrease the risk of dementia. Translational Psychiatry 7 (5):e1117. doi: 10.1038/tp.2017.90.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. 2013. Diagnostic and statistical manual of mental disorders (DSM-5^®). Arlington, Virginia: American Psychiatric Pub.
   Google Scholar
• Baek, S. C., B. Choi, S.-J. Nam, and H. Kim. 2018. Inhibition of monoamine oxidase A and B by demethoxycurcumin and bisdemethoxycurcumin. Journal of Applied Biological Chemistry 61 (2):187–90. doi: 10.3839/jabc.2018.027.
   Google Scholar
• Bava, S. V., V. T. Puliyappadamba, A. Deepti, A. Nair, D. Karunagaran, and R. J. Anto. 2018. Sensitization of taxol-induced apoptosis by curcumin involves down-regulation of nuclear factor-κ B and the serine/threonine kinase akt and is independent of tubulin polymerization. Journal of Biological Chemistry 293 (31):12283. doi: 10.1074/jbc.AAC118.004745.
   PubMed Web of Science ®Google Scholar
• Beck, A. T., N. Epstein, G. Brown, and R. A. Steer. 1988. An inventory for measuring clinical anxiety: Psychometric properties. Journal of Consulting and Clinical Psychology 56 (6):893. doi: 10.1037/0022-006X.56.6.893.
   PubMed Web of Science ®Google Scholar
• Beck, A. T., C. Ward, M. Mendelson, J. Mock, and J. Erbaugh. 1961. An inventory for measuring depression. Archives of General Psychiatry 4:561–71. doi: 10.1001/archpsyc.1961.01710120031004.
   PubMed Web of Science ®Google Scholar
• Benammi, H., O. El Hiba, A. Romane, and H. Gamrani. 2014. A blunted anxiolytic like effect of curcumin against acute lead induced anxiety in rat: Involvement of serotonin. Acta Histochemica 116 (5):920–5. doi: 10.1016/j.acthis.2014.03.002.
   PubMed Web of Science ®Google Scholar
• Bergman, J., C. Miodownik, Y. Bersudsky, S. Sokolik, P. P. Lerner, A. Kreinin, J. Polakiewicz, and V. Lerner. 2013. Curcumin as an add-on to antidepressive treatment: A randomized, double-blind, placebo-controlled, pilot clinical study. Clinical Neuropharmacology 36 (3):73–7. doi: 10.1097/WNF.0b013e31828ef969.
   PubMed Web of Science ®Google Scholar
• Brondino, N., M. Rocchetti, L. Fusar‐Poli, E. Codrons, L. Correale, M. Vandoni, C. Barbui, and P. Politi. 2017. A systematic review of cognitive effects of exercise in depression. Acta Psychiatrica Scandinavica 135 (4):285–95. doi: 10.1111/acps.12690.
   PubMed Web of Science ®Google Scholar
• Brondino, N., L. Fusar‐Poli, C. Panisi, and P. Politi. 2017. Potential neuroprotective effects of curcumin against dementia. In: Neuroprotective effects of phytochemicals in neurological disorders, ed. T. Farooqui and A. A. Farooqui, 435–336. New York: Wiley.
   Google Scholar
• Brondino, N., S. Re, A. Boldrini, A. Cuccomarino, N. Lanati, F. Barale, and P. Politi. 2014. Curcumin as a therapeutic agent in dementia: A mini systematic review of human studies. The Scientific World Journal 2014:1. doi: 10.1155/2014/174282.
   Google Scholar
• Busner, J., and S. D. Targum. 2007. The clinical global impressions scale: Applying a research tool in clinical practice. Psychiatry (Edgmont) 4 (7):28.
   PubMedGoogle Scholar
• Ceremuga, T. E., K. Helmrick, Z. Kufahl, J. Kelley, B. Keller, F. Philippe, J. Golder, and G. Padrón. 2017. Investigation of the anxiolytic and antidepressant effects of curcumin, a compound from turmeric (curcuma longa), in the adult male Sprague-Dawley rat. Holistic Nursing Practice 31 (3):193–203. doi: 10.1097/HNP.0000000000000208.
   PubMed Web of Science ®Google Scholar
• Esmaily, H., A. Sahebkar, M. Iranshahi, S. Ganjali, A. Mohammadi, G. Ferns, and M. Ghayour-Mobarhan. 2015. An investigation of the effects of curcumin on anxiety and depression in obese individuals: A randomized controlled trial. Chinese Journal of Integrative Medicine 21 (5):332–8. doi: 10.1007/s11655-015-2160-z.
   PubMed Web of Science ®Google Scholar
• Finberg, J. P. M., and J. M. Rabey. 2016. Inhibitors of MAO-A and MAO-B in psychiatry and neurology. Frontiers in Pharmacology 7:340. doi: 10.3389/fphar.2016.00340.
   PubMed Web of Science ®Google Scholar
• Fleck, M. P. A., M. F. Poirier‐Littre, J. ‐D. Guelfi, M. C. Bourdel, and H. Loo. 1995. Factorial structure of the 17‐item Hamilton depression rating scale. Acta Psychiatrica Scandinavica 92 (3):168–72. doi: 10.1111/j.1600-0447.1995.tb09562.x.
   PubMed Web of Science ®Google Scholar
• Franco-Robles, E., A. Campos-Cervantes, B. O. Murillo-Ortiz, J. Segovia, S. López-Briones, P. Vergara, V. Pérez-Vázquez, M. S. Solís-Ortiz, and J. Ramírez-Emiliano. 2014. Effects of curcumin on brain-derived neurotrophic factor levels and oxidative damage in obesity and diabetes. Applied Physiology, Nutrition, and Metabolism 39 (2):211–8. doi: 10.1139/apnm-2013-0133.
   PubMed Web of Science ®Google Scholar
• Gilhotra, N., and D. Dhingra. 2010. GABAergic and nitriergic modulation by curcumin for its antianxiety-like activity in mice. Brain Research 1352:167–75. doi: 10.1016/j.brainres.2010.07.007.
   PubMed Web of Science ®Google Scholar
• Goethe, J. W., S. B. Woolley, A. A. Cardoni, B. A. Woznicki, and D. A. Piez. 2007. Selective serotonin reuptake inhibitor discontinuation: Side effects and other factors that influence medication adherence. Journal of Clinical Psychopharmacology 27 (5):451–8. doi: 10.1097/jcp.0b013e31815152a5.
   PubMed Web of Science ®Google Scholar
• Higgins, J. P. Y., D. G. Altman, P. C. Gøtzsche, P. Jüni, D. Moher, A. D. Oxman, J. Savović, K. F. Schulz, L. Weeks, and J. A. C. Sterne. 2011. The cochrane collaboration’s tool for assessing risk of bias in randomised trials. BMJ 343 (2):d5928. doi: 10.1136/bmj.d5928.
   PubMed Web of Science ®Google Scholar
• Higgins, J. P. T., and S. Green. 2017. Cochrane handbook for systematic reviews of interventions Version 5.1. 0 (updated March 2011). The Cochrane Collaboration, 2011. http://www.cochrane-handbook.org.
   Google Scholar
• Hurley, L. L., L. Akinfiresoye, E. Nwulia, A. Kamiya, A. A. Kulkarni, and Y. Tizabi. 2013. Antidepressant-like effects of curcumin in WKY rat model of depression is associated with an increase in hippocampal BDNF. Behavioural Brain Research 239:27–30. doi: 10.1016/j.bbr.2012.10.049.
   PubMed Web of Science ®Google Scholar
• Kanchanatawan, B., S. Tangwongchai, A. Sughondhabhirom, S. Suppapitiporn, S. Hemrunrojn, A. F. Carvalho, and M. Maes. 2018. Add-on treatment with curcumin has antidepressive effects in Thai patients with major depression: Results of a randomized double-blind placebo-controlled study. Neurotoxicity Research 33 (3):621–33. doi: 10.1007/s12640-017-9860-4.
   PubMed Web of Science ®Google Scholar
• Kaufmann, F. N., M. Gazal, C. Ribeiro Bastos, M. Pinto Kaster, and G. Ghisleni. 2016. Curcumin in depressive disorders: An overview of potential mechanisms, preclinical and clinical findings. European Journal of Pharmacology 784:192–8. doi: 10.1016/j.ejphar.2016.05.026.
   PubMed Web of Science ®Google Scholar
• Kiecolt-Glaser, J. K., H. M. Derry, and C. P. Fagundes. 2015. Inflammation: Depression fans the flames and feasts on the heat. The American Journal of Psychiatry 172 (11):1075–91. doi: 10.1176/appi.ajp.2015.15020152.
   PubMed Web of Science ®Google Scholar
• Kozela, M., M. Bobak, A. Besala, A. Micek, R. Kubinova, S. Malyutina, D. Denisova, M. Richards, H. Pikhart, A. Peasey, et al. 2016. The association of depressive symptoms with cardiovascular and all-cause mortality in Central and Eastern Europe: Prospective results of the HAPIEE study. European Journal of Preventive Cardiology 23 (17):1839–47., doi: 10.1177/2047487316649493.
   PubMed Web of Science ®Google Scholar
• Kulkarni, S. K., A. Dhir, and K. K. Akula. 2009. Potentials of curcumin as an antidepressant. TheScientificWorldJournal 9:1233–41. doi: 10.1100/tsw.2009.137.
   PubMedGoogle Scholar
• Kunnumakkara, A. B., D. Bordoloi, G. Padmavathi, J. Monisha, N. K. Roy, S. Prasad, and B. B. Aggarwal. 2017. Curcumin, the golden nutraceutical: Multitargeting for multiple chronic diseases. British Journal of Pharmacology 174 (11):1325–48. doi: 10.1111/bph.13621.
   PubMed Web of Science ®Google Scholar
• Lao, C. D., M. T. Ruffin, D. Normolle, D. D. Heath, S. I. Murray, J. M. Bailey, M. E. Boggs, J. Crowell, C. L. Rock, and D. E. Brenner. 2006. Dose escalation of a curcuminoid formulation. BMC Complementary and Alternative Medicine 6 (1):10. doi: 10.1186/1472-6882-6-10.
   PubMedGoogle Scholar
• Lee, B., and H. Lee. 2018. Systemic administration of curcumin affect anxiety-related behaviors in a rat model of posttraumatic stress disorder via activation of serotonergic systems. Evidence-Based Complementary and Alternative Medicine 2018:1. doi: 10.1155/2018/9041309.
   Web of Science ®Google Scholar
• Lopresti, A. L. 2019. Curcumin for neuropsychiatric disorders: A review of in vitro, animal and human studies. Journal of Psychopharmacology 31 (3):287–302. doi: 10.1177/0269881116686883.
   Web of Science ®Google Scholar
• Lopresti, A. L., and P. D. Drummond. 2017. Efficacy of curcumin, and a saffron/curcumin combination for the treatment of major depression: A randomised, double-blind, placebo-controlled study. Journal of Affective Disorders 207:188–96. doi: 10.1016/j.jad.2016.09.047.
   PubMed Web of Science ®Google Scholar
• Lopresti, A. L., M. Maes, G. L. Maker, S. D. Hood, and P. D. Drummond. 2014. Curcumin for the treatment of major depression: A randomised, double-blind, placebo controlled study. Journal of Affective Disorders 167:368–75. doi: 10.1016/j.jad.2014.06.001.
   PubMed Web of Science ®Google Scholar
• MacQueen, G. M., and K. A. Memedovich. 2017. Cognitive dysfunction in major depression and bipolar disorder: Assessment and treatment options. Psychiatry and Clinical Neurosciences 71 (1):18–27. doi: 10.1111/pcn.12463.
   PubMed Web of Science ®Google Scholar
• Maier, W., R. Buller, M. Philipp, and I. Heuser. 1988. The Hamilton anxiety scale: Reliability, validity and sensitivity to change in anxiety and depressive disorders. Journal of Affective Disorders 14 (1):61–8. doi: 10.1016/0165-0327(88)90072-9.
   PubMed Web of Science ®Google Scholar
• Martinowich, K., H. Manji, and B. Lu. 2007. New insights into BDNF function in depression and anxiety. Nature Neuroscience 10 (9):1089. doi: 10.1038/nn1971.
   PubMed Web of Science ®Google Scholar
• Moher, D., A. Liberati, J. Tetzlaff, and D. G. Altman. 2009. Preferred reporting items for systematic reviews and Meta-analyses: The PRISMA statement. Annals of Internal Medicine 151 (4):264–9. doi: 10.7326/0003-4819-151-4-200908180-00135.
   PubMed Web of Science ®Google Scholar
• Montgomery, S. A., and M. Åsberg. 1979. A new depression scale designed to be sensitive to change. The British Journal of Psychiatry: The Journal of Mental Science 134:382–9. doi: 10.1192/bjp.134.4.382.
   PubMed Web of Science ®Google Scholar
• National Collaborating Centre for Mental Health. 2010. Depression: The treatment and management of depression in adults (updated edition). Leicester, UK: British Psychological Society.
   Google Scholar
• Ng, Q. X., S. Shao Hong Koh, H. Wuen Chan, and C. Yih Xian Ho. 2017. Clinical use of curcumin in depression: A meta-analysis. Journal of the American Medical Directors Association 18 (6):503–8. doi: 10.1016/j.jamda.2016.12.071.
   PubMed Web of Science ®Google Scholar
• Olfson, M., C. Blanco, and S. C. Marcus. 2016. Treatment of adult depression in the United States treatment of adult depression in the United States treatment of adult depression in the United States. JAMA Internal Medicine 176 (10):1482–91. doi: 10.1001/jamainternmed.2016.5057.
   PubMed Web of Science ®Google Scholar
• Panahi, Y., R. Badeli, G. ‐R. Karami, and A. Sahebkar. 2015. Investigation of the efficacy of adjunctive therapy with bioavailability‐boosted curcuminoids in major depressive disorder. Phytotherapy Research 29 (1):17–21. doi: 10.1002/ptr.5211.
   PubMed Web of Science ®Google Scholar
• Prasad, S., and B. B. Aggarwal. 2011. Turmeric, the golden spice: From traditional medicine to modern medicine. In: Herbal medicine: Biomolecular and clinical aspects, ed. I. F. F. Benzie and S. Wachtel-Galor, 273–298. 2nd ed. Boca Raton (FL): CRC Press/Taylor & Francis.
   Google Scholar
• Ravindran, A. V., L. G. Balneaves, G. Faulkner, A. Ortiz, D. McIntosh, R. L. Morehouse, L. Ravindran, L. N. Yatham, S. H. Kennedy, R. W. Lam, et al. 2016. Canadian network for mood and anxiety treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: Section 5. Complementary and alternative medicine treatments. The Canadian Journal of Psychiatry 61 (9):576–87.
   PubMed Web of Science ®Google Scholar
• Rosenthal, R., and R. L. Rosnow. 1991. Essentials of behavioral research: Methods and data analysis. New York: McGraw-Hill.
   Google Scholar
• Rush, A. J., C. M. Gullion, M. R. Basco, R. B. Jarrett, and M. H. Trivedi. 1996. The inventory of depressive symptomatology (IDS): Psychometric properties. Psychological Medicine 26 (3):477–86. doi: 10.1017/S0033291700035558.
   PubMed Web of Science ®Google Scholar
• Sahebkar, A. 2014. Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? Evidence from a meta-analysis. Phytotherapy Research 28 (5):633–42. doi: 10.1002/ptr.5045.
   PubMed Web of Science ®Google Scholar
• Sanmukhani, J., A. Anovadiya, and C. B. Tripathi. 2011. Evaluation of antidepressant like activity of curcumin and its combination with fluoxetine and imipramine: An acute and chronic study. Acta Poloniae Pharmaceutica 68 (5):769–75.
   PubMed Web of Science ®Google Scholar
• Sanmukhani, J., V. Satodia, J. Trivedi, T. Patel, D. Tiwari, B. Panchal, A. Goel, and C. Bhanu Tripathi. 2014. Efficacy and safety of curcumin in major depressive disorder: A randomized controlled trial. Phytotherapy Research 28 (4):579–85. doi: 10.1002/ptr.5025.
   PubMed Web of Science ®Google Scholar
• Sansone, R. A., and L. A. Sansone. 2012. Antidepressant adherence: Are patients taking their medications? Innovations in Clinical Neuroscience 9 (5–6):41.
   PubMedGoogle Scholar
• Setiawati, M. C., Z. Ikawati, and I. Nyoman Kertia. 2017. Antiinflamatory and antidepressive activities of extract curcuma xanthorrhiza roxb in systemic lupus erythematosus. Indonesian Journal of Pharmacy 28 (3):185. doi: 10.14499/indonesianjpharm28iss3pp185.
   Web of Science ®Google Scholar
• Sinyor, M., J. Rezmovitz, and A. Zaretsky. 2016. Screen all for depression. British Medical Journal 352:i1617. doi: 10.1136/bmj.i1617.
   Google Scholar
• Tang, M., and C. Taghibiglou. 2017. The mechanisms of action of curcumin in Alzheimer's disease. Journal of Alzheimer's Disease: JAD 58 (4):1003–16. doi: 10.3233/JAD-170188.
   PubMed Web of Science ®Google Scholar
• Weitz, E., A. Kleiboer, A. van Straten, and P. Cuijpers. 2018. The effects of psychotherapy for depression on anxiety symptoms: A meta-analysis. Psychological Medicine 48 (13):2140–52. doi: 10.1017/S0033291717003622.
   PubMed Web of Science ®Google Scholar
• Williams, J. B. W. 1988. A structured interview guide for the Hamilton depression rating scale. Archives of General Psychiatry 45 (8):742–7. doi: 10.1001/archpsyc.1988.01800320058007.
   PubMed Web of Science ®Google Scholar
• World Health Organization. 2017. Depression and other common mental disorders: Global health estimates. Geneva: World Health Organization.
   Google Scholar
• Wu, Y., F. Wang, E. A. Reece, and P. Yang. 2015. Curcumin ameliorates high glucose-induced neural tube defects by suppressing cellular stress and apoptosis. American Journal of Obstetrics and Gynecology 212 (6):802.e1. doi: 10.1016/j.ajog.2015.01.017.
   Web of Science ®Google Scholar
• Yu, J.-J., L.-B. Pei, Y. Zhang, Z.-Y. Wen, and J.-L. Yang. 2015. Chronic supplementation of curcumin enhances the efficacy of antidepressants in major depressive disorder: A randomized, double-blind, placebo-controlled pilot study. Journal of Clinical Psychopharmacology 35:406–10. doi: 10.1097/JCP.0000000000000352.
   PubMed Web of Science ®Google Scholar
• Zhu, L. N., X. Mei, Z. G. Zhang, Y. P. Xie, and F. Lang. 2019. Curcumin intervention for cognitive function in different types of people: A systematic review and meta-analysis. Phytotherapy Research 33 (3):524–33. doi: 10.1002/ptr.6257.
   PubMed Web of Science ®Google Scholar
• Zigmond, A. S., and R. P. Snaith. 1983. The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica 67 (6):361–70. doi: 10.1111/j.1600-0447.1983.tb09716.x.
   PubMed Web of Science ®Google Scholar